01 10Aranesp
02 5Darbepoetin Alfa Injection Syringe [KKF]
03 7Nesp
Main Therapeutic Indication : Hematology
Currency : USD
2020 Revenue in Millions : 1,568
2019 Revenue in Millions : 1,729
Growth (%) : -9
Main Therapeutic Indication : Nephrology
Currency : USD
2020 Revenue in Millions : 99
2019 Revenue in Millions : 378
Growth (%) : -74
Main Therapeutic Indication : Nephrology
Currency : USD
2020 Revenue in Millions : 239
2019 Revenue in Millions : 133
Growth (%) : 80
Main Therapeutic Indication : Hematology
Currency : USD
2021 Revenue in Millions : 1,480
2020 Revenue in Millions : 1,568
Growth (%) : -6
Main Therapeutic Indication : Nephrology
Currency : USD
2021 Revenue in Millions : 88
2020 Revenue in Millions : 99
Growth (%) : 0
Main Therapeutic Indication : Nephrology
Currency : USD
2021 Revenue in Millions : 188
2020 Revenue in Millions : 239
Growth (%) : -12
Main Therapeutic Indication : Hematology
Currency : USD
2022 Revenue in Millions : 1,421
2021 Revenue in Millions : 1,480
Growth (%) : -4
Main Therapeutic Indication : Nephrology
Currency : USD
2022 Revenue in Millions : 83
2021 Revenue in Millions : 88
Growth (%) : -5
Main Therapeutic Indication : Nephrology
Currency : USD
2022 Revenue in Millions : 133
2021 Revenue in Millions : 188
Growth (%) : -29
Main Therapeutic Indication : Nephrology
Currency : USD
2023 Revenue in Millions : 83
2022 Revenue in Millions : 83
Growth (%) : 12
LOOKING FOR A SUPPLIER?